世界の静脈内鎮静剤市場2023年:企業・地域・タイプ・用途別分析

◆英語タイトル:Global Intravenous Sedatives Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

GlobalInfoResearchが発行した調査報告書(GIR23SM7893)◆商品コード:GIR23SM7893
◆発行会社(リサーチ会社):GlobalInfoResearch
◆発行日:2023年9月
◆ページ数:108
◆レポート形式:英語 / PDF
◆納品方法:Eメール(注文後2-3日)
◆調査対象地域:グローバル
◆産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥522,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD5,220 ⇒換算¥783,000見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,044,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

GlobalInfoResearchの最新の調査によると、世界の静脈内鎮静剤の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx%の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の静脈内鎮静剤市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 静脈内鎮静剤の成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

静脈内鎮静剤市場はタイプと用途によって区分されます。2018年~2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・ジアゼパム、ミダゾラム、プロポフォール、その他

用途別セグメント
・病院、診療所、その他

主要な市場プレーヤー
・Astrazeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B.Braun、Maruishi、Piramal、Hikma Pharmaceuticals、Mylan、Nhwa、Hengrui、Lunan、Humanwell

地域別セグメントは次の地域・国をカバーします。
・北米(米国、カナダ、メキシコ)
・ヨーロッパ(ドイツ、フランス、イギリス、ロシア、イタリア)
・アジア太平洋(日本、中国、韓国、インド、東南アジア、オーストラリア)
・南アメリカ(ブラジル、アルゼンチン、コロンビア)
・中東およびアフリカ(サウジアラビア、UAE、エジプト、南アフリカ)

本調査レポートの内容は計15章あります。
・第1章では、静脈内鎮静剤製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な静脈内鎮静剤メーカーの企業概要、2019年~2022年までの静脈内鎮静剤の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な静脈内鎮静剤メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年~2029年までの地域別静脈内鎮静剤の販売量、売上、成長性を示しています。
・第5、6章では、2018年~2029年までの静脈内鎮静剤のタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年~2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年~2029年までの主要地域での静脈内鎮静剤市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および静脈内鎮静剤の産業チェーンを掲載しています。
・第14、15章では、静脈内鎮静剤の販売チャネル、販売業者、顧客、調査結果について説明します。

・市場概要
– 静脈内鎮静剤の概要
– タイプ別分析(2018年vs2022年vs2029年):ジアゼパム、ミダゾラム、プロポフォール、その他
– 用途別分析(2018年vs2022年vs2029年):病院、診療所、その他
– 世界の静脈内鎮静剤市場規模・予測
– 世界の静脈内鎮静剤生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報(企業概要、製品概要、販売量、価格、売上)
– Astrazeneca、Fresenius-Kabi、AbbVie、Baxter Healthcare、B.Braun、Maruishi、Piramal、Hikma Pharmaceuticals、Mylan、Nhwa、Hengrui、Lunan、Humanwell
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年:ジアゼパム、ミダゾラム、プロポフォール、その他
・用途別分析2018年-2029年:病院、診療所、その他
・静脈内鎮静剤の北米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:アメリカ、カナダ、メキシコなど
・静脈内鎮静剤のヨーロッパ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ドイツ、イギリス、フランス、ロシア、イタリアなど
・静脈内鎮静剤のアジア市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:中国、日本、韓国、インド、東南アジア、オーストラリアなど
・静脈内鎮静剤の南米市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:ブラジル、アルゼンチンなど
・静脈内鎮静剤の中東・アフリカ市場
– タイプ別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模:サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学(成長要因、阻害要因、トレンド、ポーターズファイブフォース分析)
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

❖ レポートの目次 ❖

1 Market Overview
1.1 Product Overview and Scope of Intravenous Sedatives
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Intravenous Sedatives Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Diazepam
1.3.3 Midazolam
1.3.4 Propofol
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Intravenous Sedatives Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Clinic
1.4.4 Other
1.5 Global Intravenous Sedatives Market Size & Forecast
1.5.1 Global Intravenous Sedatives Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Intravenous Sedatives Sales Quantity (2018-2029)
1.5.3 Global Intravenous Sedatives Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Astrazeneca
2.1.1 Astrazeneca Details
2.1.2 Astrazeneca Major Business
2.1.3 Astrazeneca Intravenous Sedatives Product and Services
2.1.4 Astrazeneca Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Astrazeneca Recent Developments/Updates
2.2 Fresenius-Kabi
2.2.1 Fresenius-Kabi Details
2.2.2 Fresenius-Kabi Major Business
2.2.3 Fresenius-Kabi Intravenous Sedatives Product and Services
2.2.4 Fresenius-Kabi Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Fresenius-Kabi Recent Developments/Updates
2.3 AbbVie
2.3.1 AbbVie Details
2.3.2 AbbVie Major Business
2.3.3 AbbVie Intravenous Sedatives Product and Services
2.3.4 AbbVie Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 AbbVie Recent Developments/Updates
2.4 Baxter Healthcare
2.4.1 Baxter Healthcare Details
2.4.2 Baxter Healthcare Major Business
2.4.3 Baxter Healthcare Intravenous Sedatives Product and Services
2.4.4 Baxter Healthcare Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Baxter Healthcare Recent Developments/Updates
2.5 B.Braun
2.5.1 B.Braun Details
2.5.2 B.Braun Major Business
2.5.3 B.Braun Intravenous Sedatives Product and Services
2.5.4 B.Braun Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 B.Braun Recent Developments/Updates
2.6 Maruishi
2.6.1 Maruishi Details
2.6.2 Maruishi Major Business
2.6.3 Maruishi Intravenous Sedatives Product and Services
2.6.4 Maruishi Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Maruishi Recent Developments/Updates
2.7 Piramal
2.7.1 Piramal Details
2.7.2 Piramal Major Business
2.7.3 Piramal Intravenous Sedatives Product and Services
2.7.4 Piramal Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Piramal Recent Developments/Updates
2.8 Hikma Pharmaceuticals
2.8.1 Hikma Pharmaceuticals Details
2.8.2 Hikma Pharmaceuticals Major Business
2.8.3 Hikma Pharmaceuticals Intravenous Sedatives Product and Services
2.8.4 Hikma Pharmaceuticals Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Hikma Pharmaceuticals Recent Developments/Updates
2.9 Mylan
2.9.1 Mylan Details
2.9.2 Mylan Major Business
2.9.3 Mylan Intravenous Sedatives Product and Services
2.9.4 Mylan Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Mylan Recent Developments/Updates
2.10 Nhwa
2.10.1 Nhwa Details
2.10.2 Nhwa Major Business
2.10.3 Nhwa Intravenous Sedatives Product and Services
2.10.4 Nhwa Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Nhwa Recent Developments/Updates
2.11 Hengrui
2.11.1 Hengrui Details
2.11.2 Hengrui Major Business
2.11.3 Hengrui Intravenous Sedatives Product and Services
2.11.4 Hengrui Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Hengrui Recent Developments/Updates
2.12 Lunan
2.12.1 Lunan Details
2.12.2 Lunan Major Business
2.12.3 Lunan Intravenous Sedatives Product and Services
2.12.4 Lunan Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Lunan Recent Developments/Updates
2.13 Humanwell
2.13.1 Humanwell Details
2.13.2 Humanwell Major Business
2.13.3 Humanwell Intravenous Sedatives Product and Services
2.13.4 Humanwell Intravenous Sedatives Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Humanwell Recent Developments/Updates
3 Competitive Environment: Intravenous Sedatives by Manufacturer
3.1 Global Intravenous Sedatives Sales Quantity by Manufacturer (2018-2023)
3.2 Global Intravenous Sedatives Revenue by Manufacturer (2018-2023)
3.3 Global Intravenous Sedatives Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Intravenous Sedatives by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Intravenous Sedatives Manufacturer Market Share in 2022
3.4.2 Top 6 Intravenous Sedatives Manufacturer Market Share in 2022
3.5 Intravenous Sedatives Market: Overall Company Footprint Analysis
3.5.1 Intravenous Sedatives Market: Region Footprint
3.5.2 Intravenous Sedatives Market: Company Product Type Footprint
3.5.3 Intravenous Sedatives Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Intravenous Sedatives Market Size by Region
4.1.1 Global Intravenous Sedatives Sales Quantity by Region (2018-2029)
4.1.2 Global Intravenous Sedatives Consumption Value by Region (2018-2029)
4.1.3 Global Intravenous Sedatives Average Price by Region (2018-2029)
4.2 North America Intravenous Sedatives Consumption Value (2018-2029)
4.3 Europe Intravenous Sedatives Consumption Value (2018-2029)
4.4 Asia-Pacific Intravenous Sedatives Consumption Value (2018-2029)
4.5 South America Intravenous Sedatives Consumption Value (2018-2029)
4.6 Middle East and Africa Intravenous Sedatives Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Intravenous Sedatives Sales Quantity by Type (2018-2029)
5.2 Global Intravenous Sedatives Consumption Value by Type (2018-2029)
5.3 Global Intravenous Sedatives Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Intravenous Sedatives Sales Quantity by Application (2018-2029)
6.2 Global Intravenous Sedatives Consumption Value by Application (2018-2029)
6.3 Global Intravenous Sedatives Average Price by Application (2018-2029)
7 North America
7.1 North America Intravenous Sedatives Sales Quantity by Type (2018-2029)
7.2 North America Intravenous Sedatives Sales Quantity by Application (2018-2029)
7.3 North America Intravenous Sedatives Market Size by Country
7.3.1 North America Intravenous Sedatives Sales Quantity by Country (2018-2029)
7.3.2 North America Intravenous Sedatives Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Intravenous Sedatives Sales Quantity by Type (2018-2029)
8.2 Europe Intravenous Sedatives Sales Quantity by Application (2018-2029)
8.3 Europe Intravenous Sedatives Market Size by Country
8.3.1 Europe Intravenous Sedatives Sales Quantity by Country (2018-2029)
8.3.2 Europe Intravenous Sedatives Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Intravenous Sedatives Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Intravenous Sedatives Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Intravenous Sedatives Market Size by Region
9.3.1 Asia-Pacific Intravenous Sedatives Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Intravenous Sedatives Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Intravenous Sedatives Sales Quantity by Type (2018-2029)
10.2 South America Intravenous Sedatives Sales Quantity by Application (2018-2029)
10.3 South America Intravenous Sedatives Market Size by Country
10.3.1 South America Intravenous Sedatives Sales Quantity by Country (2018-2029)
10.3.2 South America Intravenous Sedatives Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Intravenous Sedatives Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Intravenous Sedatives Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Intravenous Sedatives Market Size by Country
11.3.1 Middle East & Africa Intravenous Sedatives Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Intravenous Sedatives Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Intravenous Sedatives Market Drivers
12.2 Intravenous Sedatives Market Restraints
12.3 Intravenous Sedatives Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Intravenous Sedatives and Key Manufacturers
13.2 Manufacturing Costs Percentage of Intravenous Sedatives
13.3 Intravenous Sedatives Production Process
13.4 Intravenous Sedatives Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Intravenous Sedatives Typical Distributors
14.3 Intravenous Sedatives Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Intravenous Sedatives Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Intravenous Sedatives Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Astrazeneca Basic Information, Manufacturing Base and Competitors
Table 4. Astrazeneca Major Business
Table 5. Astrazeneca Intravenous Sedatives Product and Services
Table 6. Astrazeneca Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Astrazeneca Recent Developments/Updates
Table 8. Fresenius-Kabi Basic Information, Manufacturing Base and Competitors
Table 9. Fresenius-Kabi Major Business
Table 10. Fresenius-Kabi Intravenous Sedatives Product and Services
Table 11. Fresenius-Kabi Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Fresenius-Kabi Recent Developments/Updates
Table 13. AbbVie Basic Information, Manufacturing Base and Competitors
Table 14. AbbVie Major Business
Table 15. AbbVie Intravenous Sedatives Product and Services
Table 16. AbbVie Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. AbbVie Recent Developments/Updates
Table 18. Baxter Healthcare Basic Information, Manufacturing Base and Competitors
Table 19. Baxter Healthcare Major Business
Table 20. Baxter Healthcare Intravenous Sedatives Product and Services
Table 21. Baxter Healthcare Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Baxter Healthcare Recent Developments/Updates
Table 23. B.Braun Basic Information, Manufacturing Base and Competitors
Table 24. B.Braun Major Business
Table 25. B.Braun Intravenous Sedatives Product and Services
Table 26. B.Braun Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. B.Braun Recent Developments/Updates
Table 28. Maruishi Basic Information, Manufacturing Base and Competitors
Table 29. Maruishi Major Business
Table 30. Maruishi Intravenous Sedatives Product and Services
Table 31. Maruishi Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Maruishi Recent Developments/Updates
Table 33. Piramal Basic Information, Manufacturing Base and Competitors
Table 34. Piramal Major Business
Table 35. Piramal Intravenous Sedatives Product and Services
Table 36. Piramal Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Piramal Recent Developments/Updates
Table 38. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 39. Hikma Pharmaceuticals Major Business
Table 40. Hikma Pharmaceuticals Intravenous Sedatives Product and Services
Table 41. Hikma Pharmaceuticals Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Hikma Pharmaceuticals Recent Developments/Updates
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Major Business
Table 45. Mylan Intravenous Sedatives Product and Services
Table 46. Mylan Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Mylan Recent Developments/Updates
Table 48. Nhwa Basic Information, Manufacturing Base and Competitors
Table 49. Nhwa Major Business
Table 50. Nhwa Intravenous Sedatives Product and Services
Table 51. Nhwa Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Nhwa Recent Developments/Updates
Table 53. Hengrui Basic Information, Manufacturing Base and Competitors
Table 54. Hengrui Major Business
Table 55. Hengrui Intravenous Sedatives Product and Services
Table 56. Hengrui Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Hengrui Recent Developments/Updates
Table 58. Lunan Basic Information, Manufacturing Base and Competitors
Table 59. Lunan Major Business
Table 60. Lunan Intravenous Sedatives Product and Services
Table 61. Lunan Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Lunan Recent Developments/Updates
Table 63. Humanwell Basic Information, Manufacturing Base and Competitors
Table 64. Humanwell Major Business
Table 65. Humanwell Intravenous Sedatives Product and Services
Table 66. Humanwell Intravenous Sedatives Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Humanwell Recent Developments/Updates
Table 68. Global Intravenous Sedatives Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 69. Global Intravenous Sedatives Revenue by Manufacturer (2018-2023) & (USD Million)
Table 70. Global Intravenous Sedatives Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 71. Market Position of Manufacturers in Intravenous Sedatives, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 72. Head Office and Intravenous Sedatives Production Site of Key Manufacturer
Table 73. Intravenous Sedatives Market: Company Product Type Footprint
Table 74. Intravenous Sedatives Market: Company Product Application Footprint
Table 75. Intravenous Sedatives New Market Entrants and Barriers to Market Entry
Table 76. Intravenous Sedatives Mergers, Acquisition, Agreements, and Collaborations
Table 77. Global Intravenous Sedatives Sales Quantity by Region (2018-2023) & (K Units)
Table 78. Global Intravenous Sedatives Sales Quantity by Region (2024-2029) & (K Units)
Table 79. Global Intravenous Sedatives Consumption Value by Region (2018-2023) & (USD Million)
Table 80. Global Intravenous Sedatives Consumption Value by Region (2024-2029) & (USD Million)
Table 81. Global Intravenous Sedatives Average Price by Region (2018-2023) & (US$/Unit)
Table 82. Global Intravenous Sedatives Average Price by Region (2024-2029) & (US$/Unit)
Table 83. Global Intravenous Sedatives Sales Quantity by Type (2018-2023) & (K Units)
Table 84. Global Intravenous Sedatives Sales Quantity by Type (2024-2029) & (K Units)
Table 85. Global Intravenous Sedatives Consumption Value by Type (2018-2023) & (USD Million)
Table 86. Global Intravenous Sedatives Consumption Value by Type (2024-2029) & (USD Million)
Table 87. Global Intravenous Sedatives Average Price by Type (2018-2023) & (US$/Unit)
Table 88. Global Intravenous Sedatives Average Price by Type (2024-2029) & (US$/Unit)
Table 89. Global Intravenous Sedatives Sales Quantity by Application (2018-2023) & (K Units)
Table 90. Global Intravenous Sedatives Sales Quantity by Application (2024-2029) & (K Units)
Table 91. Global Intravenous Sedatives Consumption Value by Application (2018-2023) & (USD Million)
Table 92. Global Intravenous Sedatives Consumption Value by Application (2024-2029) & (USD Million)
Table 93. Global Intravenous Sedatives Average Price by Application (2018-2023) & (US$/Unit)
Table 94. Global Intravenous Sedatives Average Price by Application (2024-2029) & (US$/Unit)
Table 95. North America Intravenous Sedatives Sales Quantity by Type (2018-2023) & (K Units)
Table 96. North America Intravenous Sedatives Sales Quantity by Type (2024-2029) & (K Units)
Table 97. North America Intravenous Sedatives Sales Quantity by Application (2018-2023) & (K Units)
Table 98. North America Intravenous Sedatives Sales Quantity by Application (2024-2029) & (K Units)
Table 99. North America Intravenous Sedatives Sales Quantity by Country (2018-2023) & (K Units)
Table 100. North America Intravenous Sedatives Sales Quantity by Country (2024-2029) & (K Units)
Table 101. North America Intravenous Sedatives Consumption Value by Country (2018-2023) & (USD Million)
Table 102. North America Intravenous Sedatives Consumption Value by Country (2024-2029) & (USD Million)
Table 103. Europe Intravenous Sedatives Sales Quantity by Type (2018-2023) & (K Units)
Table 104. Europe Intravenous Sedatives Sales Quantity by Type (2024-2029) & (K Units)
Table 105. Europe Intravenous Sedatives Sales Quantity by Application (2018-2023) & (K Units)
Table 106. Europe Intravenous Sedatives Sales Quantity by Application (2024-2029) & (K Units)
Table 107. Europe Intravenous Sedatives Sales Quantity by Country (2018-2023) & (K Units)
Table 108. Europe Intravenous Sedatives Sales Quantity by Country (2024-2029) & (K Units)
Table 109. Europe Intravenous Sedatives Consumption Value by Country (2018-2023) & (USD Million)
Table 110. Europe Intravenous Sedatives Consumption Value by Country (2024-2029) & (USD Million)
Table 111. Asia-Pacific Intravenous Sedatives Sales Quantity by Type (2018-2023) & (K Units)
Table 112. Asia-Pacific Intravenous Sedatives Sales Quantity by Type (2024-2029) & (K Units)
Table 113. Asia-Pacific Intravenous Sedatives Sales Quantity by Application (2018-2023) & (K Units)
Table 114. Asia-Pacific Intravenous Sedatives Sales Quantity by Application (2024-2029) & (K Units)
Table 115. Asia-Pacific Intravenous Sedatives Sales Quantity by Region (2018-2023) & (K Units)
Table 116. Asia-Pacific Intravenous Sedatives Sales Quantity by Region (2024-2029) & (K Units)
Table 117. Asia-Pacific Intravenous Sedatives Consumption Value by Region (2018-2023) & (USD Million)
Table 118. Asia-Pacific Intravenous Sedatives Consumption Value by Region (2024-2029) & (USD Million)
Table 119. South America Intravenous Sedatives Sales Quantity by Type (2018-2023) & (K Units)
Table 120. South America Intravenous Sedatives Sales Quantity by Type (2024-2029) & (K Units)
Table 121. South America Intravenous Sedatives Sales Quantity by Application (2018-2023) & (K Units)
Table 122. South America Intravenous Sedatives Sales Quantity by Application (2024-2029) & (K Units)
Table 123. South America Intravenous Sedatives Sales Quantity by Country (2018-2023) & (K Units)
Table 124. South America Intravenous Sedatives Sales Quantity by Country (2024-2029) & (K Units)
Table 125. South America Intravenous Sedatives Consumption Value by Country (2018-2023) & (USD Million)
Table 126. South America Intravenous Sedatives Consumption Value by Country (2024-2029) & (USD Million)
Table 127. Middle East & Africa Intravenous Sedatives Sales Quantity by Type (2018-2023) & (K Units)
Table 128. Middle East & Africa Intravenous Sedatives Sales Quantity by Type (2024-2029) & (K Units)
Table 129. Middle East & Africa Intravenous Sedatives Sales Quantity by Application (2018-2023) & (K Units)
Table 130. Middle East & Africa Intravenous Sedatives Sales Quantity by Application (2024-2029) & (K Units)
Table 131. Middle East & Africa Intravenous Sedatives Sales Quantity by Region (2018-2023) & (K Units)
Table 132. Middle East & Africa Intravenous Sedatives Sales Quantity by Region (2024-2029) & (K Units)
Table 133. Middle East & Africa Intravenous Sedatives Consumption Value by Region (2018-2023) & (USD Million)
Table 134. Middle East & Africa Intravenous Sedatives Consumption Value by Region (2024-2029) & (USD Million)
Table 135. Intravenous Sedatives Raw Material
Table 136. Key Manufacturers of Intravenous Sedatives Raw Materials
Table 137. Intravenous Sedatives Typical Distributors
Table 138. Intravenous Sedatives Typical Customers
List of Figures
Figure 1. Intravenous Sedatives Picture
Figure 2. Global Intravenous Sedatives Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Intravenous Sedatives Consumption Value Market Share by Type in 2022
Figure 4. Diazepam Examples
Figure 5. Midazolam Examples
Figure 6. Propofol Examples
Figure 7. Other Examples
Figure 8. Global Intravenous Sedatives Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Intravenous Sedatives Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Clinic Examples
Figure 12. Other Examples
Figure 13. Global Intravenous Sedatives Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Intravenous Sedatives Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Intravenous Sedatives Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Intravenous Sedatives Average Price (2018-2029) & (US$/Unit)
Figure 17. Global Intravenous Sedatives Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Intravenous Sedatives Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Intravenous Sedatives by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Intravenous Sedatives Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Intravenous Sedatives Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Intravenous Sedatives Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Intravenous Sedatives Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Intravenous Sedatives Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Intravenous Sedatives Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Intravenous Sedatives Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Intravenous Sedatives Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Intravenous Sedatives Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Intravenous Sedatives Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Intravenous Sedatives Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Intravenous Sedatives Average Price by Type (2018-2029) & (US$/Unit)
Figure 32. Global Intravenous Sedatives Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Intravenous Sedatives Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Intravenous Sedatives Average Price by Application (2018-2029) & (US$/Unit)
Figure 35. North America Intravenous Sedatives Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Intravenous Sedatives Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Intravenous Sedatives Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Intravenous Sedatives Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Intravenous Sedatives Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Intravenous Sedatives Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Intravenous Sedatives Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Intravenous Sedatives Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Intravenous Sedatives Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Intravenous Sedatives Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Intravenous Sedatives Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Intravenous Sedatives Consumption Value Market Share by Region (2018-2029)
Figure 55. China Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Intravenous Sedatives Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Intravenous Sedatives Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Intravenous Sedatives Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Intravenous Sedatives Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Intravenous Sedatives Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Intravenous Sedatives Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Intravenous Sedatives Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Intravenous Sedatives Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Intravenous Sedatives Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Intravenous Sedatives Market Drivers
Figure 76. Intravenous Sedatives Market Restraints
Figure 77. Intravenous Sedatives Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Intravenous Sedatives in 2022
Figure 80. Manufacturing Process Analysis of Intravenous Sedatives
Figure 81. Intravenous Sedatives Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の静脈内鎮静剤市場2023年:企業・地域・タイプ・用途別分析(Global Intravenous Sedatives Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆